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Thiols affect a variety of cell functions, an effect known as redox
regulation. We show here that treatment (1–2 h) of cells with 0.1–5
mM N-acetyl-L-cysteine (NAC) increases surface protein thiol ex-
pression in human peripheral blood mononuclear cells. This effect
is not associated with changes in cellular glutathione (GSH) and is
also observed with a non-GSH precursor thiol N-acetyl-D-cysteine
or with GSH itself, which is not cell-permeable, suggesting a direct
reducing action. NAC did not augment protein SH in the cytosol,
indicating that they are already maximally reduced under normal,
nonstressed, conditions. By using labeling with a non permeable,
biotinylated SH reagent followed by two-dimensional gel electro-
phoresis and analysis by MS, we identified some of the proteins
associated with the membrane that are reduced by NAC. These
proteins include the following: integrin -4, myosin heavy chain
(nonmuscle type A), myosin light-chain alkali (nonmuscle isoform),
and-actin. NAC pretreatment augmented integrin-4-dependent
fibronectin adhesion and aggregation of Jurkat cells without
changing its expression by fluorescence-activated cell sorter, sug-
gesting that reduction of surface disulfides can affect proteins
function. We postulate that some of the activities of NAC or other
thiol antioxidants may not only be due to free radical scavenging
or increase of intracellular GSH and subsequent effects on tran-
scription factors, but could modify the redox state of functional
membrane proteins with exofacial SH critical for their activity.
There is a growing interest in the role of thiol-disulfideoxidoreduction as a mechanism of redox regulation of cel-
lular functions and gene expression (1, 2). This concept is based
on the cellular effects of oxidative stress, glutathione (GSH)
depletion, or by the use of thiol antioxidants or precursors of
GSH synthesis, including N-acetyl-L-cysteine (NAC).
However, some effects of NAC seem not mediated by an
increase of GSH, as suggested by experiments with inhibitors of
GSH synthesis or the D-stereoisomer of NAC (D-NAC) that
cannot be converted to GSH. These effects include inhibition of
apoptosis (3), antiproliferative effect (4), inhibition of epidermal
growth factor receptor activation (5), or enhancement of IL-1-
induced iNOS expression (6).
Recent interest has focused on oxidoreduction of proteins’
cysteines as a means of redox regulation of their function. In
particular, protein SHs can be reversibly oxidized to form intra-
or interchain disulfides, glutathionylated proteins (7, 8), or
S-nitrosothiols (9). It is possible that thiol antioxidants like NAC
interfere with these mechanisms by acting as reductants (4).
Whereas most of the attention has focused on intracellular
targets or redox regulation, including transcription factors (10),
or signaling molecules (11), surface thiols have also been sug-
gested to be regulated in lymphocytes and are increased in
HIV-infected patients (12). Among the membrane proteins that
can be modified by oxidoreduction there are ion channels and
the N-methyl-D-aspartate (NMDA) receptor (13, 14).
In the present study, we investigated protein thiols at the cell
surface as possible candidate targets of redox regulation. To this
end, we studied the effect of NAC on the expression of surface
SH in human peripheral blood mononuclear cells (PBMCs). We
used two different methods of detection of surface SH. A first
method, which is more quantitative, relies on the use of Ellman’s
reagent, 5,5-dithiobis(2-nitrobenzoic acid) (DTNB). Incubation
of cells with DTNB, which is not cell-permeable, will cause
release of the chromogenic product reflecting the amount of
surface SH (6, 15).
A second method utilizes a cell-impermeable, biotinylated SH
reagent N-(biotinoyl)-N-(iodoacetyl)ethylendiamine (BIAM)
to label the cell-surface proteins (16, 17). We applied this
method to proteomic analysis to identify protein SH specifically
reduced in NAC-treated cells. As one of the proteins identified
as targets of NAC-reducing action was an integrin, we also
studied the effect of NAC on integrin-mediated cell adhesion.
Materials and Methods
Cells and Treatments. Human PBMCs, which were isolated by
using standard FicollHypaque gradients from buffy coat of
healthy donors, were plated at 2.5  106 in 3 ml in 25 cm2 tissue
culture flasks for DTNB experiments. For experiments using
BIAM labeling and membrane purification, cells were plated in
75 cm2 of tissue culture flasks (5  107 cells per flask). Cells
were treated as indicated in Results, with any of the following
additions: NAC, buthionine sulfoximine (BSO), H2O2, GSH (all
from Sigma), and D-NAC (Research Organics), which were
washed twice with PBS, and used for biochemical analyses as
described below. Jurkat cells were cultured in RPMI medium
1640 supplemented with 10% FBS and treated as described
below.
Determination of Cell-Surface Protein Thiols with DTNB. DTNB was
added to the cells to a final concentration of 200 M in PBS.
After 20 min at room temperature, the supernatant was har-
vested and its absorbance read at 412 nm. Results are expressed
as nanomoles SH per 106 cells calculated from a standard curve
with NAC.
Determination of Cell-Surface Protein Thiols with BIAM. Cells were
resuspended at 1 106 per ml in medium and treated for 15 min
at 37°C with 100 M BIAM, then plasma membranes were
isolated essentially as described (18). Briefly, the cells were
homogenized in 250 mM sucrose containing 10 mM Hepes
NaOH (pH 7.5) and 1 mM EDTA by using a Potter Teflon
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: VLA-4, integrin -4; NAC, N-acetyl-L-cysteine; D-NAC, D-stereoisomer of
NAC; GSH, glutathione; PBMC, peripheral blood mononuclear cell; DTNB, 5,5-dithiobis(2-
nitrobenzoic acid); BIAM, N-(biotinoyl-N-(iodoacetyl)ethylendiamine; BSO, buthionine
sulfoximine.
§To whom correspondence should be addressed at: Mario Negri Institute, Via Eritrea 62,
20157 Milan, Italy. E-mail: ghezzi@marionegri.it.
© 2003 by The National Academy of Sciences of the USA
www.pnas.orgcgidoi10.1073pnas.2434516100 PNAS  December 9, 2003  vol. 100  no. 25  14737–14741
BI
O
CH
EM
IS
TR
Y
homogenizer. The homogenate was centrifuged at 700 g for 10
min, and the resulting supernatant fraction was centrifuged again
at 100,000  g for 35 min. The pellet was then resuspended in
PBS containing 2% Zwittergent 3–10 (Calbiochem; ref. 19), and
the lysate was clarified by centrifugation.
Electrophoretic Separation of Proteins and Detection of Protein SH by
Immunoblotting. A minimum of 40g of membrane proteins were
reduced with 5% 2-mercaptoethanol, and two-dimensional gel
electrophoresis (2-DE) was performed essentially as in ref. 8,
except that 0.5% 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate was added to the sample buffer. Proteins were
then transferred to a nitrocellulose membrane and probed with
streptavidin-peroxidase. Parallel gels were stained with Coo-
massie blue and used for protein identification.
Protein Identification. Protein spots were excised from 2-DE gels,
destained for few hours in 25 mM ammonium bicarbonate40%
ethanol, and washed with a sequential increasing percentage of
acetonitrile. Proteins were in gel-digested overnight at 30°C with
trypsin (Promega) at a concentration of 12 ngml in a 25 mM
ammonium bicarbonate10% acetonitrile solution. Peptide
mass fingerprinting (PMF) was performed on a Bruker ReflexIII
matrix-assisted laser desorptionionization (MALDI) mass
spectrometer by using -cyano-4-hydroxycinnamic acid (Bruker,
Billerica, MA) as a matrix. The mass spectra were externally
calibrated with a mixture of seven standard peptides in the range
between 1,000 and 3,000 Da. Data generated were subjected to
database (NCBInr) searching by using as programs MASCOT
(http:www.matrixscience.com) and PROFOUND (http:
prowl.rockefeller.edu), allowing up to one missed trypsin cleav-
age and a mass tolerance of  0.2 Da. Postsource decay (PSD)
MALDI MS of selected peptide ions and analysis with the
MS-Tag searching algorithm (http:prospector.ucsf.edu) were
necessary to confirm identifications in some cases. All of the
identified proteins were in the expected size range and pI based
on position in the gel.
GSH Assay. Cells (1  106 per sample) were deproteinized with
100 l of 10% sulfosalicylic acid, left for 30 min on ice,
centrifuged at 17,000  g for 5 min at 4°C, and GSH measured
according to the methods of Tietze (20).
Cell Adhesion Assay. Seven gml of human fibronectin (Sigma)
was used to coat 48-well plates for 2 h at 37°C; then, plates were
saturated with 2% BSA for 30 min at 37°C and washed twice
with PBS. Jurkat cells were then seeded onto the wells for 2h
at 37°C; then, nonadherent cells were aspirated, and the wells
were rinsed with PBS. Adhering cells were fixed overnight with
2% formaldehyde and stained with eosin Y for 30 min. Eosin
Y was then extracted by addition of a mixture of 1% of glacial
acetic acid and 50% ethanol, and absorbance was measured at
540 nm.
Integrin -4 (VLA-4) Expression. VLA-4 antigen expression was
detected on Jurkat cells by indirect immunofluorescence with a
monoclonal anti-VLA-4 (clone HP17) and flow cytometry.
Staining of cells was performed according to standard protocols
and flow cytometry analysis was performed by using a FACS-
Calibur cytometer (Becton Dickinson).
Fig. 1. Time course (A) and dose response (B) of NAC-induced increase of surface SH expression. PBMCs (106 cells per ml) were cultured with 5 mM NAC for the
indicated time (A), after which surface thiols were quantified with DTNB. In the experiment shown in B, cells were incubated for 2 h with the indicated
concentration of NAC. Data are the mean of duplicate experiments.
Fig. 2. BIAM labeling pattern of membrane proteins from PBMCs under basal conditions (A) or treated with 5 mM NAC for 2 h (B). Proteins were separated
by 2-DE based on pI (4–10 nonlinear gradient, left to right) and molecular weight (SDS12% PAGE, top to bottom). (C) A Coomassie blue-stained gel from control
cells.
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Results
NAC Treatment Preferentially Reduces Surface Protein Disulfides. To
study the effect of NAC on the levels of exofacial protein thiols,
as measured by using the DTNB method, cells were treated with
NAC and then extensively washed with PBS until no SH could
be detected in the washings by DTNB assay. The cells were then
incubated with DTNB for measuring cell-surface SH. As shown
in Fig. 1A, NAC rapidly increased surface SH levels (by 5-fold
in the experiment shown), reaching a plateau within 2 h. Fig. 1B
shows the results of dose-response experiments, indicating that
maximal effect of NAC was observed at 0.5 mM concentration,
with an approximate EC50 of 0.1 mM.
To confirm that the increase in DTNB reactivity was not an
artifact due to a carryover of NAC, or to the fact that a small
amount of DTNB might enter into the cells, we purified mem-
branes, then we measured their SH. A comparable increase in
free SH was found both on whole cells (control, 99  18; NAC,
478  27 nmol per 106 cells; mean  SD, n  3) and on purified
membranes (control, 69  3; NAC, 321  12 nmol per 106 cells;
mean  SD, n  3. P  0.01 vs. control).
Identification of Surface Membrane Proteins Whose SH Expression Is
Augmented by NAC. In these experiments, cells were incubated for
2 h with 5 mM NAC, then surface SHs were labeled with BIAM.
Membranes were then purified, and proteins were analyzed by
2-DE, followed by immunoblotting with streptavidin. Fig. 2
shows that very little SH expression was present in control cells
(Fig. 2 A), whereas several protein spots became labeled after
NAC treatment (Fig. 2B). The protein spots indicated were
identified as myosin heavy chain, nonmuscle type A (NMMHC-
IIA) (spot no. 1), VLA-4 (spot no. 2), -actin (spot no. 3), and
myosin light-chain alkali, nonmuscle isoform (MLC) (spot no. 4;
Table 1). The proteins were identified by PMF with significantly
high probability-based Mowse and Z scores, except VLA-4, for
which PSD analysis of the fragment ion at 969.7 mz was
necessary for unambiguous identification.
NAC Reduces Surface Proteins Directly Through Its Reducing Activity.
To study whether the effect of NAC was mediated by GSH, we
tested D-NAC, which is not a precursor for GSH synthesis, or
GSH itself, which, unlike NAC, does not enter the cells. As
shown in Fig. 3, all these thiol compounds, tested in the same
experimental conditions used for NAC, increased surface SH,
suggesting that they act through a direct reducing action.
Role of Endogenous GSH in the Maintenance of Surface SH. To study
whether intracellular GSH is implicated in maintaining surface
SH under basal conditions (i.e., in the absence of any exogenous
NAC or reducing agents), we treated cells overnight with the
inhibitor of GSH synthesis, BSO. As shown in Fig. 4, BSO caused
a 50% decrease in GSH, and this result was paralleled by an 85%
decrease in surface SH.
Effect of NAC and SH-Blocking Agents on VLA-4-Dependent Adhesion.
To investigate the effect of NAC-induced augmentation of SH
expression in VLA-4, we used human Jurkat cells that represent
a well studied model for studying adhesion to fibronectin (21).
Cells were treated with 5 mM NAC for 2 h, then we studied their
adhesion to fibronectin. As shown in Fig. 5, NAC increases cell
aggregations and adhesion. Incubation of the cells, after NAC
treatment, with anti-VLA-4 antibody, inhibited both adhesion
and aggregation, indicating that the effect of NAC is specific for
VLA-4. Cell adhesion was then quantitated by staining the cells
attached to fibronectin-coated plates with eosin Y and reading
the absorbance in a microplate reader. As shown in Fig. 6, NAC
pretreatment augmented cell adhesion by 35%, an effect that
was abolished by anti-VLA-4. Under these experimental condi-
Table 1. Surface membrane proteins sensitive to NAC treatment
Spot no. Protein name NCBI accession no.
PBM
score
Z
score
Percent sequence
coverage
No. of matching
peptides
MALDI MS
identification methods
1 NMMHC-IIA gi189036 171 2.43 24 27 PMF
2 VLA-4 gi4504749 — 0.12 7 6 PSD
3 -actin gi4501885 82 2.1 37 13 PMF
4 MLC gi576 96 2.43 46 9 PMF
Spot nos. refer to Fig. 3. PBM and Z scores are the probability scores obtained with MASCOT and PROFOUND programs with PMF data. PSD analysis was used as
confirmation when PMF data did not give significant scores (PBM score 63 and Z score 1.65). MALDI, matrix-assisted laser desorptionionization.
Fig. 3. Effect of NAC, D-NAC, or GSH on surface SH. Cells were treated for 2 h
with a 5-mM concentration of the indicated compound. Surface SHs were
quantitated by using the DTNB method. Data are mean SE (n3). *, P0.01
vs. control by Student’s t test.
Fig. 4. Effect of prolonged treatment with BSO on intracellular GSH (black
bars) and surface SH (white bars). Cells were treated with 1 mM BSO for 24 h.
Surface SH was measured by using the DTNB method. Data are mean SE (n
3). *, P  0.05 vs. control.
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tions, surface expression of VLA-4, as measured by flow cytom-
etry, was unchanged (Fig. 7).
Discussion
Recent studies (12) indicate a role for surface thiols as targets
of redox regulation in the immune system. We show that NAC
augments the expression of surface SH on PBMCs. This effect
was observed at concentrations of 0.1–5 mM, which was in the
lower range of those used in vitro to study regulatory effects of
NAC (often in the 10–30 mM range). This result indicates that
redox-sensitive cysteines on the cell surface are mostly in an
oxidized state, very likely because they are at the interface with
the highly oxidizing extracellular environment, and can be easily
reduced by mild reductants such as NAC or GSH. From these
experiments, it is not known whether the protein cysteines
reduced by NAC are oxidized as protein disulfides, or mixed
disulfides with small molecular weight thiols. Garant et al. (22)
have shown that NAC can reduce the insulin receptor -subunit
disulfides, indicating that some of the SH might actually derive
from reduction of interchain disulfides. NAC could also reduce
intrachain disulfides that will normally be in the oxidized state.
Another possibility is that some cysteines on the cell surface are
present in part as mixed disulfides with small molecular weight
thiols (e.g., GSH, cysteine), as it was described for soluble
proteins such as albumin (23).
The effect of NAC is probably due to a direct reducing effect.
In fact, D-NAC, which is not a GSH precursor, and GSH itself,
which is not cell-permeable, had a comparable effect on surface
SH. On the other hand, in the absence of exogenous reductants,
cellular GSH seems to be required for maintaining surface SH
in a reduced state, as indicated by the fact that GSH depletion
with BSO markedly decreased surface SH.
A second aspect of the present study was the identification
of the surface proteins susceptible of redox regulation by using
a proteomic approach. There is currently a paucity of data
Fig. 5. NAC increases the adhesions of Jurkat cells to fibronectin. The adhesion assay was performed by using control or NAC (5 mM for 2 h)-treated Jurkat
cells, as described in Materials and Methods. The cells were photographed after staining with eosin Y.
Fig. 6. Quantitation of the effect of NAC on cell adhesion. Experiments were
performed exactly as in Fig. 5. Cells were solubilized and eosin Y and absor-
bance was quantitated at 540 nm. No antibody, white bars; anti-VLA-4 (10
ngml), gray bars; and anti-VLA-4 (10gml), black bars. Data are means SE
(n  3).*, P  0.01 vs. control.
Fig. 7. Surface expression of VLA-4 is unchanged by NAC. Jurkat cells were
treated with NAC (5 mM for 2 h) or left untreated. The cells were then stained
with HP17, fixed, and analyzed by FACS. VLA-4-positive cells were 77% in
control and 78% in NAC-treated cells.
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pertaining to the comprehensive analysis of surface membrane
proteins, due to the difficulty in purifying and identifying them
in addition to their relatively low abundance. Protein databases
are rapidly increasing the number of the hits and the quality
of their annotations; however, very little information is re-
ported on posttranslational modifications such as glycosyla-
tion, which is a common modification on surface membrane
proteins. Specific protein labeling has been used to selectively
separate the cell-surface proteome (16, 24). These strategies
have simplified the purification of membrane proteins, but
have added more difficulties to the MS analysis of the labeled
proteins. For example, in our PMF experiments, we did not
detect any peptide labeled with BIAM, suggesting a poor
ionization efficiency of the peptide containing such a modi-
fication. All in all, the identification of surface membrane
proteins still remains a challenge.
Some of the proteins identified were cytoskeletal proteins,
including NMMHC-IIA, MLC, and -actin. All these proteins
can be found associated with the cell membrane (25) and may
become accessible to BIAM, given the fluid state of the mem-
brane.
One protein identified was the VLA-4, which is clearly located
on the cell surface. This protein has 25 cysteines, of which 18 are
engaged in disulfide bonds and 7 as free SH, and previous studies
(26) had shown that at least two of the free cysteines are
important for VLA-4 ligand binding and cell adhesion. In our
experimental conditions, NAC markedly augments the expres-
sion of free SH in VLA-4 and VLA-4-dependent adhesion. It is
important to note that a 2-h treatment with NAC did not alter
VLA-4 surface expression, as measured by f luorescence-
activated cell sorter (FACS) analysis.
Reactive oxygen species are also known to regulate cell
adhesion at various steps, for instance, by regulating protein
phosphatases implicated in integrin signaling (27). Thiol anti-
oxidants inhibit the induction of VCAM and ICAM expression
and diminish inflammation in vivo (28, 29).
In conclusion, we demonstrated that thiols can affect the redox
state of several membrane proteins. We hypothesize that some
of the effects of exogenous NAC may not be mediated by an
increase of intracellular GSH, its free radical scavenging prop-
erties, or a reduction of intracellular disulfides; but, rather, by a
reduction of membrane protein disulfides. Oxidoreduction of
membrane SH could result in the modification of receptors,
transporters, or of proteins acting as redox sensor. In fact,
whereas most of the redox-sensitive molecular targets are intra-
cellular proteins, including transcription factors and signaling
proteins (30), some membrane receptors, including ion channels,
NMDA receptor, glucose transporter, GLUT1, and insulin
receptor are known to be redox-sensitive (22, 30). This finding
might be important, because it could provide a mechanism for
the activity of extracellular, or exogenously administered, thiol
compounds, in conditions where this cannot be explained by an
increase in cellular GSH or a as a free radical scavenger. The
identification of these redox sensitive targets is obviously im-
portant for characterizing these mechanisms at the molecular
level.
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